Solid Biosciences Receives FDA Fast Track Designation for SGT-501 First-in-Class Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Solid Biosciences Inc., which acquired UF startup AavantiBio, announced that it received Fast Track designation from the U.S. Food and Drug Administration (FDA) for SGT-501, the Company’s novel, AAV-based investigational gene therapy for the treatment of catecholaminergic polymorphic ventricular tachycardia (CPVT).
Tech Tuesday: University of Florida Students Build Cars and Compete With Gator Motorsport
In this week’s Tech Tuesday, UF Innovate spotlights Gator Motorsports, where University of Florida students design, build, and race a Formula-style car while gaining real-world engineering and management experience.
University of Florida Research Spending at Record $1.33 Billion for FY2025, New Awards at $1.2 Billion
University of Florida faculty conducted a record $1.33 billion in research in fiscal year 2025, advancing new medical treatments, supporting Florida’s farmers and helping to grow statewide industries such as aerospace and semiconductors.
New AI Model Aims To Increase Lactation, Breastfeeding Rates in NICU
UF researchers have developed artificial intelligence models to help increase lactation and breastfeeding rates in the NICU at UF Health Shands Hospital in Gainesville.
UF Nursing Redesignated Center of Excellence for Teaching
The University of Florida College of Nursing has been redesignated a Center of Excellence by the National League for Nursing in recognition of its role as a national leader in nursing education and teaching.
Scientists Will Use a $1M Grant To Build a Support System Addressing Sea Level Rise and Flooding in South Florida
UF researchers have received a $1 million grant from the National Science Foundation to address one of South Florida’s most pressing environmental challenges: groundwater flooding and saltwater intrusion driven by sea level rise.
Surprising Finding Could Pave Way for Universal Cancer Vaccine
A University of Florida study found that, like a one-two punch, pairing a test vaccine with commonly used anticancer drugs known as immune checkpoint inhibitors triggered a strong antitumor response.
Taming Wild Fires Before They Spiral: Part 2 – User Experience
UF Innovate | Accelerate resident client Fire Neural Network (FNN) was spotlighted for its AI-powered wildfire detection system, which emphasizes user experience in addressing critical environmental challenges.
SandboxAQ and iOncologi Partner To Accelerate Brain Cancer Treatment With AI-Driven Drug Discovery for Glioblastoma
SandboxAQ and UF startup iOncologi have announced a strategic collaboration to co-develop, validate, and commercialize a novel high-fidelity mRNA vaccine targeting glioblastoma—the most common and aggressive malignant brain tumor in adults.
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement To Support ONP-002 Clinical Development
UF Innovate | Accelerate graduate Oragenics, Inc., has announced a manufacturing agreement with Sterling Pharma Solutions, a leading U.S.-based CDMO with multiple development and production facilities.